APA (7th ed.) Citation

Babel, R., Wehler, E., Syed, S. S., Turkistani, F., Rajagopalan, K., & Chirovsky, D. (2025). RWD95 Healthcare Cost and Resource Utilization among First Line (1L) Treated Patients with Metastatic Non-small Cell Lung Cancer (mNSCLC): Analysis of SEER-Medicare Linked Claims in the US. Value in Health, 28(6), S380. https://doi.org/10.1016/j.jval.2025.04.1678

Chicago Style (17th ed.) Citation

Babel, Riddhi, Elizabeth Wehler, Safiuddin Shoeb Syed, Fatema Turkistani, Kitty Rajagopalan, and Diana Chirovsky. "RWD95 Healthcare Cost and Resource Utilization Among First Line (1L) Treated Patients with Metastatic Non-small Cell Lung Cancer (mNSCLC): Analysis of SEER-Medicare Linked Claims in the US." Value in Health 28, no. 6 (2025): S380. https://doi.org/10.1016/j.jval.2025.04.1678.

MLA (9th ed.) Citation

Babel, Riddhi, et al. "RWD95 Healthcare Cost and Resource Utilization Among First Line (1L) Treated Patients with Metastatic Non-small Cell Lung Cancer (mNSCLC): Analysis of SEER-Medicare Linked Claims in the US." Value in Health, vol. 28, no. 6, 2025, p. S380, https://doi.org/10.1016/j.jval.2025.04.1678.